%0 Journal Article
%A Stratigos, Alexander J
%A Garbe, Claus
%A Dessinioti, Clio
%A Lebbe, Celeste
%A Bataille, Veronique
%A Bastholt, Lars
%A Dreno, Brigitte
%A Fargnoli, Maria Concetta
%A Forsea, Ana Maria
%A Frenard, Cecille
%A Harwood, Catherine Α
%A Hauschild, Axel
%A Hoeller, Christoph
%A Kandolf-Sekulovic, Lidija
%A Kaufmann, R
%A Kelleners-Smeets, Nicole Wj
%A Malvehy, Josep
%A Del Marmol, Veronique
%A Middleton, Mark R
%A Moreno-Ramirez, David
%A Pellecani, Giovanni
%A Peris, Ketty
%A Saiag, Philippe
%A van den Beuken-van Everdingen, Marieke H J
%A Vieira, Ricardo
%A Zalaudek, Iris
%A Eggermont, Alexander M M
%A Grob, Jean-Jacques
%A European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO) and the European Organization for Research and Treatment of Cancer (EORTC)
%T European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention.
%D 2020
%U http://hdl.handle.net/10668/15183
%X Invasive cutaneous squamous cell carcinoma (cSCC) is one of the most common cancers in the white populations, accounting for 20% of all cutaneous malignancies. Factors implicated in cSCC etiopathogenesis include ultraviolet radiation exposure and chronic photoaging, age, male sex, immunosuppression, smoking and genetic factors. A collaboration of multidisciplinary experts from the European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO) and the European Organisation of Research and Treatment of Cancer (EORTC) was formed to update recommendations on cSCC classification, diagnosis, risk stratification, staging and prevention, based on current literature, staging systems and expert consensus. Common cSCCs are typically indolent tumors, and most have a good prognosis with 5-year cure rates of greater than 90%, and a low rate of metastases (
%K Diagnosis
%K High-risk common primary cSCC
%K Imaging
%K Invasive cutaneous squamous cell carcinoma
%K Locally advanced Cscc
%K Low-risk
%K Metastatic cSCC
%K Prevention
%K Prognosis
%K Staging
%~